Renal effects of guideline‐directed medical therapies in heart failure: a consensus document from the Heart Failure Association of the European Society of Cardiology
Published 2022 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Renal effects of guideline‐directed medical therapies in heart failure: a consensus document from the Heart Failure
Association of the European Society of Cardiology
Authors
Keywords
-
Journal
EUROPEAN JOURNAL OF HEART FAILURE
Volume 24, Issue 4, Pages 603-619
Publisher
Wiley
Online
2022-03-03
DOI
10.1002/ejhf.2471
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- 2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure
- (2022) et al. EUROPEAN JOURNAL OF HEART FAILURE
- Empagliflozin Effects on Pulmonary Artery Pressure in Patients with Heart Failure: Results from EMpagliflozin Evaluation By MeasuRing ImpAct on HemodynamiCs in PatiEnts with Heart Failure (EMBRACE-HF) Trial
- (2021) Michael E. Nassif et al. CIRCULATION
- Dapagliflozin in HFrEF Patients Treated With Mineralocorticoid Receptor Antagonists
- (2021) Li Shen et al. JACC-Heart Failure
- Renal Function and the Effects of Vericiguat in Patients with Worsening Heart Failure with Reduced Ejection Fraction: Insights from VICTORIA ( VerICiguaT Global Study in Subjects with HFrEF ) Trial
- (2021) Adriaan A. Voors et al. EUROPEAN JOURNAL OF HEART FAILURE
- Kidney Function and Outcomes in Patients Hospitalized with Heart Failure
- (2021) Ravi B. Patel et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Kidney Function After Initiation and Discontinuation of Empagliflozin in Heart Failure Patients With and Without Type 2 Diabetes: Insights From the EMPERIAL Trials
- (2021) Stefan D. Anker et al. CIRCULATION
- Pitfalls in Using Estimated Glomerular Filtration Rate Slope as a Surrogate for the Effect of Drugs on the Risk of Serious Adverse Renal Outcomes in Clinical Trials of Patients With Heart Failure
- (2021) Milton Packer Circulation-Heart Failure
- Effect of Omecamtiv Mecarbil on the Pharmacokinetics of Metformin, a Probe Substrate for MATE1/MATE2-K, in Healthy Subjects
- (2021) Ashit Trivedi et al. CLINICAL DRUG INVESTIGATION
- Empagliflozin in Heart Failure with a Preserved Ejection Fraction
- (2021) Stefan D. Anker et al. NEW ENGLAND JOURNAL OF MEDICINE
- Empagliflozin and Major Renal Outcomes in Heart Failure
- (2021) Milton Packer et al. NEW ENGLAND JOURNAL OF MEDICINE
- Empagliflozin-Induced Changes in Epicardial Fat
- (2021) Wilfried Mullens et al. JACC-Heart Failure
- Natriuresis‐guided therapy in acute heart failure: rationale and design of the Pragmatic Urinary Sodium‐based treatment algoritHm in Acute Heart Failure ( PUSH‐AHF ) trial
- (2021) Jozine M. Maaten et al. EUROPEAN JOURNAL OF HEART FAILURE
- Worsening renal function in acute heart failure in the context of diuretic response
- (2021) Johanna E. Emmens et al. EUROPEAN JOURNAL OF HEART FAILURE
- Rationale and Design of the Efficacy of a Standardized Diuretic Protocol in Acute Heart Failure Study
- (2021) Jeroen Dauw et al. ESC Heart Failure
- Evaluation of kidney function throughout the heart failure trajectory – a position statement from the Heart Failure Association of the European Society of Cardiology
- (2020) Wilfried Mullens et al. EUROPEAN JOURNAL OF HEART FAILURE
- Randomized, double‐blind, placebo‐controlled, multicentre pilot study on the effects of empagliflozin on clinical outcomes in patients with acute decompensated heart failure (EMPA‐RESPONSE‐AHF)
- (2020) Kevin Damman et al. EUROPEAN JOURNAL OF HEART FAILURE
- Empagliflozin in Heart Failure: Diuretic and Cardio-Renal Effects
- (2020) Matthew Griffin et al. CIRCULATION
- Unravelling the interplay between hyperkalaemia, renin-angiotensin-aldosterone inhibitor use and clinical outcomes. Data from 9222 chronic heart failure patients of the ESC-HFA-EORP Heart Failure Long-Term Registry
- (2020) Patrick Rossignol et al. EUROPEAN JOURNAL OF HEART FAILURE
- Effect of Dapagliflozin on Worsening Heart Failure and Cardiovascular Death in Patients With Heart Failure With and Without Diabetes
- (2020) Mark C. Petrie et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Vericiguat in Patients with Heart Failure and Reduced Ejection Fraction
- (2020) Paul W. Armstrong et al. NEW ENGLAND JOURNAL OF MEDICINE
- Effects of dapagliflozin on congestion assessed by remote pulmonary artery pressure monitoring
- (2020) Wilfried Mullens et al. ESC Heart Failure
- Cardiac and Kidney Benefits of Empagliflozin in Heart Failure Across the Spectrum of Kidney Function: Insights from the EMPEROR-Reduced Trial
- (2020) Faiez Zannad et al. CIRCULATION
- Efficacy of Dapagliflozin on Renal Function and Outcomes in Patients with Heart Failure with Reduced Ejection Fraction: Results of DAPA-HF
- (2020) Pardeep S. Jhund et al. CIRCULATION
- Angiotensin-Neprilysin Inhibition and Renal Outcomes in Heart Failure With Preserved Ejection Fraction
- (2020) Finnian R. Mc Causland et al. CIRCULATION
- SGLT2 inhibitors in patients with heart failure with reduced ejection fraction: a meta-analysis of the EMPEROR-Reduced and DAPA-HF trials
- (2020) Faiez Zannad et al. LANCET
- Cardiovascular and Renal Outcomes with Empagliflozin in Heart Failure
- (2020) Milton Packer et al. NEW ENGLAND JOURNAL OF MEDICINE
- Effect of Finerenone on Chronic Kidney Disease Outcomes in Type 2 Diabetes
- (2020) George L. Bakris et al. NEW ENGLAND JOURNAL OF MEDICINE
- Effects of the Soluble Guanylate Cyclase Stimulator Praliciguat in Diabetic Kidney Disease
- (2020) John P. Hanrahan et al. Clinical Journal of the American Society of Nephrology
- Effects of empagliflozin on renal sodium and glucose handling in patients with acute heart failure
- (2020) Eva M. Boorsma et al. EUROPEAN JOURNAL OF HEART FAILURE
- Empagliflozin and renal sodium handling: an intriguing smart osmotic diuretic
- (2020) Wilfried Mullens et al. EUROPEAN JOURNAL OF HEART FAILURE
- Effect of Empagliflozin on Hemodynamics in Patients With Heart Failure and Reduced Ejection Fraction
- (2020) Massar Omar et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Cardiac Myosin Activation with Omecamtiv Mecarbil in Systolic Heart Failure
- (2020) John R. Teerlink et al. NEW ENGLAND JOURNAL OF MEDICINE
- Cardiovascular and Renal Outcomes of Mineralocorticoid Receptor Antagonist Use in PARAGON-HF
- (2020) Karola S. Jering et al. JACC-Heart Failure
- The use of diuretics in heart failure with congestion - a position statement from the Heart Failure Association of the European Society of Cardiology
- (2019) Wilfried Mullens et al. EUROPEAN JOURNAL OF HEART FAILURE
- Clinical practice update on heart failure 2019: pharmacotherapy, procedures, devices and patient management. An expert consensus meeting report of The Heart Failure Association of the European Society of Cardiology
- (2019) Petar M. Seferovic et al. EUROPEAN JOURNAL OF HEART FAILURE
- Trends in Kidney Function Outcomes Following RAAS Inhibition in Patients With Heart Failure With Reduced Ejection Fraction
- (2019) Wendy McCallum et al. AMERICAN JOURNAL OF KIDNEY DISEASES
- Evaluation of Glomerular Hemodynamic Function by Empagliflozin in Diabetic Mice Using In Vivo Imaging
- (2019) Kengo Kidokoro et al. CIRCULATION
- Heart failure in chronic kidney disease: conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference
- (2019) Andrew A. House et al. KIDNEY INTERNATIONAL
- Acute declines in estimated glomerular filtration rate on enalapril and mortality and cardiovascular outcomes in patients with heart failure with reduced ejection fraction
- (2019) Wendy McCallum et al. KIDNEY INTERNATIONAL
- Change in Albuminuria and GFR as End Points for Clinical Trials in Early Stages of CKD: A Scientific Workshop Sponsored by the National Kidney Foundation in Collaboration With the US Food and Drug Administration and European Medicines Agency
- (2019) Andrew S. Levey et al. AMERICAN JOURNAL OF KIDNEY DISEASES
- Dapagliflozin in Patients with Heart Failure and Reduced Ejection Fraction
- (2019) John J.V. McMurray et al. NEW ENGLAND JOURNAL OF MEDICINE
- The renal hemodynamic effects of the SGLT2 inhibitor dapagliflozin are caused by post-glomerular vasodilatation rather than pre-glomerular vasoconstriction in metformin-treated patients with type 2 diabetes in the randomized, double-blind RED trial
- (2019) Erik J.M. van Bommel et al. KIDNEY INTERNATIONAL
- Impact of Renal Impairment on Beta-Blocker Efficacy in Patients With Heart Failure
- (2019) Dipak Kotecha et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- From molecules to patients: exploring the therapeutic role of soluble guanylate cyclase stimulators
- (2018) Peter Sandner BIOLOGICAL CHEMISTRY
- Worsening Renal Function in Patients With Acute Heart Failure Undergoing Aggressive Diuresis Is Not Associated With Tubular Injury
- (2018) Tariq Ahmad et al. CIRCULATION
- Effects of Sacubitril/Valsartan Versus Irbesartan in Patients with Chronic Kidney Disease: A Randomised Double-Blind Trial
- (2018) Richard Haynes et al. CIRCULATION
- β -Blocker Dialyzability in Maintenance Hemodialysis Patients
- (2018) Alvin Tieu et al. Clinical Journal of the American Society of Nephrology
- Interaction Between the Sodium‐Glucose–Linked Transporter 2 Inhibitor Dapagliflozin and the Loop Diuretic Bumetanide in Normal Human Subjects
- (2018) Christopher S. Wilcox et al. Journal of the American Heart Association
- Effect of neprilysin inhibition on renal function in patients with type 2 diabetes and chronic heart failure who are receiving target doses of inhibitors of the renin-angiotensin system: a secondary analysis of the PARADIGM-HF trial
- (2018) Milton Packer et al. Lancet Diabetes & Endocrinology
- Renal Effects and Associated Outcomes During Angiotensin-Neprilysin Inhibition in Heart Failure
- (2018) Kevin Damman et al. JACC-Heart Failure
- Exploiting the Natriuretic Peptide Pathway to Preserve Glomerular Filtration in Heart Failure ∗
- (2018) Wilfried Mullens et al. JACC-Heart Failure
- Worsening renal function during decongestion among patients hospitalized for heart failure: Findings from the Evaluation Study of Congestive Heart Failure and Pulmonary Artery Catheterization Effectiveness (ESCAPE) trial
- (2018) Marat Fudim et al. AMERICAN HEART JOURNAL
- Reasons for Guideline Nonadherence at Heart Failure Discharge
- (2018) Lauren G. Gilstrap et al. Journal of the American Heart Association
- Effects of Intensive Blood Pressure Lowering on Kidney Tubule Injury in CKD: A Longitudinal Subgroup Analysis in SPRINT
- (2018) Rakesh Malhotra et al. AMERICAN JOURNAL OF KIDNEY DISEASES
- Renal sodium avidity in heart failure: from pathophysiology to treatment strategies
- (2017) Wilfried Mullens et al. EUROPEAN HEART JOURNAL
- Acute kidney injury in cardiogenic shock: definitions, incidence, haemodynamic alterations, and mortality
- (2017) Tuukka Tarvasmäki et al. EUROPEAN JOURNAL OF HEART FAILURE
- Organ dysfunction, injury and failure in acute heart failure: from pathophysiology to diagnosis and management. A review on behalf of the Acute Heart Failure Committee of the Heart Failure Association (HFA) of the European Society of Cardiology (ESC)
- (2017) Veli-Pekka Harjola et al. EUROPEAN JOURNAL OF HEART FAILURE
- Progression of Renal Impairment and Chronic Kidney Disease in Chronic Heart Failure: An Analysis From GISSI-HF
- (2017) Kevin Damman et al. JOURNAL OF CARDIAC FAILURE
- Single-Nephron Glomerular Filtration Rate in Healthy Adults
- (2017) Aleksandar Denic et al. NEW ENGLAND JOURNAL OF MEDICINE
- Physicians' adherence to guideline-recommended medications in heart failure with reduced ejection fraction: data from the QUALIFY global survey
- (2016) Michel Komajda et al. EUROPEAN JOURNAL OF HEART FAILURE
- Cardiac Output and Renal Dysfunction
- (2016) Wilfried Mullens et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Aliskiren, Enalapril, or Aliskiren and Enalapril in Heart Failure
- (2016) John J.V. McMurray et al. NEW ENGLAND JOURNAL OF MEDICINE
- Empagliflozin and Progression of Kidney Disease in Type 2 Diabetes
- (2016) Christoph Wanner et al. NEW ENGLAND JOURNAL OF MEDICINE
- Renal effects of the angiotensin receptor neprilysin inhibitor LCZ696 in patients with heart failure and preserved ejection fraction
- (2015) Adriaan A. Voors et al. EUROPEAN JOURNAL OF HEART FAILURE
- Consistency of Laboratory Monitoring During Initiation of Mineralocorticoid Receptor Antagonist Therapy in Patients With Heart Failure
- (2015) Lauren B. Cooper et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- GFR Decline as an End Point for Clinical Trials in CKD: A Scientific Workshop Sponsored by the National Kidney Foundation and the US Food and Drug Administration
- (2014) Andrew S. Levey et al. AMERICAN JOURNAL OF KIDNEY DISEASES
- The kidney in congestive heart failure: ‘are natriuresis, sodium, and diuretics really the good, the bad and the ugly?’
- (2014) Frederik H. Verbrugge et al. EUROPEAN JOURNAL OF HEART FAILURE
- The effect of heart rate reduction with ivabradine on renal function in patients with chronic heart failure: an analysis from SHIFT
- (2014) Adriaan A. Voors et al. EUROPEAN JOURNAL OF HEART FAILURE
- Decline in Estimated Glomerular Filtration Rate and Subsequent Risk of End-Stage Renal Disease and Mortality
- (2014) Josef Coresh et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Sodium glucose cotransport-2 inhibition and intrarenal RAS activity in people with type 1 diabetes
- (2014) David Z.I. Cherney et al. KIDNEY INTERNATIONAL
- Angiotensin–Neprilysin Inhibition versus Enalapril in Heart Failure
- (2014) John J.V. McMurray et al. NEW ENGLAND JOURNAL OF MEDICINE
- Uptitration of Renin-Angiotensin System Blocker and Beta-Blocker Therapy in Patients Hospitalized for Heart Failure With Reduced Versus Preserved Left Ventricular Ejection Fractions
- (2013) Frederik H. Verbrugge et al. AMERICAN JOURNAL OF CARDIOLOGY
- Renal Hemodynamic Effect of Sodium-Glucose Cotransporter 2 Inhibition in Patients With Type 1 Diabetes Mellitus
- (2013) David Z.I. Cherney et al. CIRCULATION
- Incidence, Determinants, and Prognostic Significance of Hyperkalemia and Worsening Renal Function in Patients With Heart Failure Receiving the Mineralocorticoid Receptor Antagonist Eplerenone or Placebo in Addition to Optimal Medical Therapy
- (2013) Patrick Rossignol et al. Circulation-Heart Failure
- Dapagliflozin a glucose-regulating drug with diuretic properties in subjects with type 2 diabetes
- (2013) H. J. Lambers Heerspink et al. DIABETES OBESITY & METABOLISM
- Renal impairment, worsening renal function, and outcome in patients with heart failure: an updated meta-analysis
- (2013) K. Damman et al. EUROPEAN HEART JOURNAL
- Co-morbidities in patients with heart failure: an analysis of the European Heart Failure Pilot Survey
- (2013) Vincent M. van Deursen et al. EUROPEAN JOURNAL OF HEART FAILURE
- Timing of Hemoconcentration During Treatment of Acute Decompensated Heart Failure and Subsequent Survival
- (2013) Jeffrey M. Testani et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Current Evidence on Treatment of Patients With Chronic Systolic Heart Failure and Renal Insufficiency
- (2013) Kevin Damman et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Renin-Angiotensin Inhibition in Systolic Heart Failure and Chronic Kidney Disease
- (2012) Ali Ahmed et al. AMERICAN JOURNAL OF MEDICINE
- Why Do SGLT2 Inhibitors Inhibit Only 30-50% of Renal Glucose Reabsorption in Humans?
- (2012) J. Liu et al. DIABETES
- Angiotensin II Contributes to Podocyte Injury by Increasing TRPC6 Expression via an NFAT-Mediated Positive Feedback Signaling Pathway
- (2011) Tom Nijenhuis et al. AMERICAN JOURNAL OF PATHOLOGY
- Determinants and Consequences of Renal Function Variations With Aldosterone Blocker Therapy in Heart Failure Patients After Myocardial Infarction
- (2011) Patrick Rossignol et al. CIRCULATION
- Is Worsening Renal Function an Ominous Prognostic Sign in Patients With Acute Heart Failure?
- (2011) Marco Metra et al. Circulation-Heart Failure
- Effects of Beta-Adrenergic Antagonists in Patients With Chronic Kidney Disease
- (2011) Sunil V. Badve et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- An acute fall in estimated glomerular filtration rate during treatment with losartan predicts a slower decrease in long-term renal function
- (2011) Frank A. Holtkamp et al. KIDNEY INTERNATIONAL
- Potential Effects of Aggressive Decongestion During the Treatment of Decompensated Heart Failure on Renal Function and Survival
- (2010) Jeffrey M. Testani et al. CIRCULATION
- Efficacy and Safety of Carvedilol in Treatment of Heart Failure with Chronic Kidney Disease
- (2010) Ravinder K. Wali et al. Circulation-Heart Failure
- Improved survival with bisoprolol in patients with heart failure and renal impairment: an analysis of the cardiac insufficiency bisoprolol study II (CIBIS-II) trial
- (2010) Davide Castagno et al. EUROPEAN JOURNAL OF HEART FAILURE
- Activation of Na+/H+Exchanger NHE3 by Angiotensin II Is Mediated by Inositol 1,4,5-Triphosphate (IP3) Receptor-binding Protein Released with IP3(IRBIT) and Ca2+/Calmodulin-dependent Protein Kinase II
- (2010) Peijian He et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Glucose-Induced Regulation of NHEs Activity and SGLTs Expression Involves the PKA Signaling Pathway
- (2010) Olívia Beloto-Silva et al. JOURNAL OF MEMBRANE BIOLOGY
- Aldosterone: effects on the kidney and cardiovascular system
- (2010) Marie Briet et al. Nature Reviews Nephrology
- Eplerenone in Patients with Systolic Heart Failure and Mild Symptoms
- (2010) Faiez Zannad et al. NEW ENGLAND JOURNAL OF MEDICINE
- Importance of Venous Congestion for Worsening of Renal Function in Advanced Decompensated Heart Failure
- (2009) Wilfried Mullens et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- The Influence of Renal Function on Clinical Outcome and Response to β-Blockade in Systolic Heart Failure: Insights From Metoprolol CR/XL Randomized Intervention Trial in Chronic HF (MERIT-HF)
- (2008) Jalal K. Ghali et al. JOURNAL OF CARDIAC FAILURE
- The Right Ventricular Failure Risk Score
- (2008) Jennifer Cowger Matthews et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Gender differences in predictors of the decline of renal function in the general population
- (2008) Nynke Halbesma et al. KIDNEY INTERNATIONAL
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreDiscover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversation